BerGenBio ASA

BerGenBio ASA

BerGenBio is a clinical-stage biopharmaceutical company focused on developing a pipeline of first-in-class selective AXL kinase inhibitors to treat multiple aggressive cancers. The Company is a worl...

BerGenBio ASA's Basic Information

Industry
Pharmaceutical Manufacturing
Headquarters
Bergen, Vestland, Norway
Founded Year
2008
Headcount
11 - 50
Specialties
Drug discoveryDrug target discoveryEpithelial-mesenchymal transitionAggressive, drug-resistant cancerAXLoncologyacute myeloid leukaemiaNon-small cell lung cancer

BerGenBio ASA's Competitors

Motor Racing Developments (UK) Limited
Motor Racing Developments (UK) Limited

Clear Pharma
Clear Pharma

NEW Indonesia Malaysia
NEW Indonesia Malaysia

HNS Pharma Limited
HNS Pharma Limited

PROSYFAPE Group of Companies
PROSYFAPE Group of Companies

Athens, Alabama, United States

Employee Insights

Employee Function

Employee Location

BerGenBio ASA's Top Employees

people
James Lorens
Co-Founder
people
Barbara van der Hoeven
Technical Associate
people
Anna Boniecka
Research Associate
people
Eline Milde-Nævdal
Technical Associate
people
Rune Skeie
CFO

Find Your Next Customer with Better Data

Get access to over 160 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.

Top-ranked on G2 Crowd
🛡️GDPR compliantCancel anytime
Free credits every month!

Frequently Asked Questions Regarding BerGenBio ASA

Where is BerGenBio ASA's headquarter located?

BerGenBio ASA's headquarter are located at Norway.

How many employees does BerGenBio ASA have?

BerGenBio ASA has 11 - 50 employees.

What is BerGenBio ASA's official website?

BerGenBio ASA's official website is http://www.bergenbio.com

What industry does BerGenBio ASA belong to?

BerGenBio ASA is in the industry of Pharmaceutical Manufacturing

What does BerGenBio ASA do?

BerGenBio is a clinical-stage biopharmaceutical company focused on developing a pipeline of first-in-class selective AXL kinase inhibitors to treat multiple aggressive cancers. The Company is a worl...

What specialty does BerGenBio ASA have?

Drug discoveryDrug target discoveryEpithelial-mesenchymal transitionAggressive, drug-resistant cancerAXLoncologyacute myeloid leukaemiaNon-small cell lung cancer

Connect with anyone with AroundDeal today!

Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
cta